Pharmacovigilance insights into antibody–drug conjugates: a multi-database analysis of adverse events in leukemia treatment
Mining multiple databases enabled the identification of SOCs and AEs strongly associated with frequent adverse reactions to gemtuzumab ozogamicin and inotuzumab ozogamicin, offering valuable insights for clinical dosing guidance.
Authors
- Hongmei Wu (ORCID: https://orcid.org/0000-0001-9322-9186)
- Zhe Liu (ORCID: https://orcid.org/0000-0002-2251-469X)
- Sheng Wu (ORCID: https://orcid.org/0009-0007-2743-9047)
- Yiming Sun (ORCID: https://orcid.org/0000-0001-6401-7600)
- Meiling Yu
- Xuchen Fan
Institutions
- Bengbu Medical College (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1080/14740338.2025.2521365
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China